d-alpha tocopherol has been researched along with amphotericin b in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andrews, FA; Beggs, WH; Sarosi, GA | 1 |
| DRAPER, HH; JAMES, MF; JOHNSON, BC | 1 |
| Arnusch, CJ; Josten, M; Osherov, N; Sahl, HG; Shadkchan, Y; Shai, Y; Ulm, H | 1 |
| Gershkovich, P; Ibrahim, F; Sivak, O; Wasan, EK; Wasan, KM | 1 |
| Cetin, M; Gökce, M; Kuskonmaz, B; Tuncer, M; Uckan Cetinkaya, D | 1 |
| Belhachemi, MH; Belmir, S; Benbekhti, Z; Boucherit, K; Boucherit-Otmani, Z | 1 |
| Cai, S; Hou, W; Liu, F; Sun, L; Tang, X; Zhang, R; Zhu, H | 1 |
| Chen, YC; Ho, HO; Jhan, HJ; Sheu, MT; Su, CY | 1 |
| Abbasalipourkabir, R; Ghafourikhosroshahi, A; Heidarisasan, S; Maghsood, AH; Salehzadeh, A; Taheri-Azandaryan, M | 1 |
1 review(s) available for d-alpha tocopherol and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for d-alpha tocopherol and amphotericin b
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Influence of antioxidants on the bioactivity of amphotericin B.
Topics: Amphotericin B; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Candida albicans; Drug Stability; Oxidation-Reduction; Propyl Gallate; Vitamin E | 1977 |
Tri-o-cresyl phosphate as a vitamin E antagonist for the rat and lamb.
Topics: Amphotericin B; Animals; Cresols; Rats; Sheep; Sheep, Domestic; Tritolyl Phosphates; Vitamin E; Vitamin E Deficiency | 1952 |
Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B.
Topics: Amphotericin B; Animals; Antimicrobial Cationic Peptides; Aspergillus fumigatus; Bacteria; beta-Cyclodextrins; Candida albicans; Cell Membrane; Cell Membrane Permeability; Cholesterol; Cryptococcus neoformans; Drug Synergism; Erythrocytes; Hemolysis; Hydrophobic and Hydrophilic Interactions; Macrophages; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Mycoses; Species Specificity; Static Electricity; Vitamin E | 2012 |
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.
Topics: Administration, Oral; Amphotericin B; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Delivery Systems; Excipients; Kidney; Lipids; Lung; Male; Oleic Acids; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Solubility; Tissue Distribution; Vitamin E | 2013 |
Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Topics: Administration, Oral; Adolescent; Age Factors; Amphotericin B; Anticoagulants; Antifungal Agents; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; Enoxaparin; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Infant; Kaplan-Meier Estimate; Kidney Diseases; Male; Parenteral Nutrition, Total; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Turkey; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2013 |
Effects of ascorbic acid and α-tocopherol on the therapeutic index of amphotericin B.
Topics: alpha-Tocopherol; Amphotericin B; Ascorbic Acid; Candida albicans; Drug Interactions; Erythrocytes; Hemolysis; Humans; Microbial Sensitivity Tests; Oxidation-Reduction; Toxicity Tests | 2014 |
Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Carriers; Ethylene Glycols; Kidney; Liver; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Vitamin E | 2014 |
Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Animals; Biological Availability; HT29 Cells; Humans; Lecithins; Male; Micelles; Microscopy, Electron, Transmission; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Rats, Sprague-Dawley; Solubility; Time Factors; Vitamin E | 2015 |
Effects of vitamin A and vitamin E on attenuation of amphotericin B-induced side effects on kidney and liver of male Wistar rats.
Topics: Amphotericin B; Animals; Antioxidants; Kidney; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Vitamin A; Vitamin E | 2020 |